Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and effectiveness of luspatercept for transfusion-dependent anemia associated with myelodysplastic syndromes and be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Beta-thalassemia
• Myelodysplastic Syndromes

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Anemia | Phase 4 | Status: ACTIVE_NOT_RECRUITING